Aurobindo Pharma gains after its JV receives SEC recommendation for pneumococcal 15 valent vaccine

aurobindo pharma gets usfdas nod for guaifenesin extended release tablets

Aurobindo Pharma is currently trading at Rs. 442.75, up by 5.50 points or 1.26% from its previous closing of Rs. 437.25 on the BSE. The scrip opened at Rs. 440.40 and has touched a high and low of Rs. 444.80 and Rs. 438.40 respectively. So far 102108 shares were traded on the counter. The BSE … Read more